New pharmacological agents and novel cardiovascular pharmacotherapy strategies

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022 – European Heart Journal – Cardiovascular Pharmacotherapy

Commentary on Twitter

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022: a focused review by the ESC Working Group on #Pharmacotherapy ? https://t.co/DZ6FTqYwxk @jpkaski #HF #AFib #diabetes #lipids #EHJPharmacotherapy @AgewallStefan @FeliceGragnano pic.twitter.com/1DTCewbyPv

— European Society of Cardiology Journals (@ESC_Journals) May 20, 2023